Podcasts about Walgreens

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Mela Lovett. A serial entrepreneur with multiple businesses including: Landscaping (Family Lawn Services) Mortgage lending (commercial and residential) Business consulting (especially on proper business structuring)

If you’ve been to a store like CVS, Walgreens or Target in the last few years, you may have noticed a trend: more and more essentials are locked up behind plexiglass walls. The strategy started as an anti-theft measure. But there’s little evidence that it’s worked. On today’s Big Take podcast, Bloomberg’s Amanda Mull takes host Sarah Holder through the causes and consequences of the retail lock-up era — and how it’s changed the way we shop. Read more: Retailers Locked Up Their Products—and Broke Shopping in AmericaSee omnystudio.com/listener for privacy information.

Future Proof, which holds one of the industry's largest wealth conferences, invited me to hold a live podcast earlier this year with Blue Owl Co-President and Global Head of Real Assets Marc Zahr. Marc is a pioneer in the real estate space, building Blue Owl into a market leader in the triple net lease strategy, a commercial real estate investment strategy that is becoming increasingly popular for real estate investors, tenants (think large corporates like Amazon, Walgreens, Dollar General), and investors alike.Blue Owl's Real Assets business has over $67.1B AUM, owning over 5,600 assets and partnering with over 800 tenants. Marc founded Oak Street, the predecessor firm to Blue Owl, in 2009 with $17M AUM. Listening to Marc talk about the evolution of his career, building Oak Street, and running Blue Owl's Real Assets platform, it's no surprise to see why Marc and the firm have had success. His “myopic focus … perfecting his craft,” as he discussed in our conversation, his clarity of vision, and his ability to so clearly articulate his investment strategy and market opportunity have led to tremendous success for Oak Street, and now, Blue Owl.Marc and I had a fascinating and thought-provoking discussion that covered everything from the evolution of his firm, how and why he sold Oak Street to Blue Owl, the market opportunity in triple net lease real estate investing, why data center investing is a large market opportunity, how to build a high-performing investment culture, and much more.We discussed:The story of how Marc built Oak Street from a $17M real estate investment firm and grew it into Blue Owl's $67B AUM Real Assets platform.Breaking down the triple net lease real estate investment strategy.Why the industry “isn't even in the first inning” in the $20T addressable market in triple net lease real estate investing.Why data centers are a “once in a generation opportunity” due to capex supply / demand imbalance.How a bigger platform can help an asset manager scale its business.Why an evergreen structure can make sense and the story of how Blue Owl did so well with its triple net lease product on a private wealth platform that the private bank created their own product.The hardest part of educating the wealth channel on real estate and evergreen structures.Why private wealth is the biggest opportunity in the future. The advice Marc would give to someone trying to build the next great asset manager.Thanks Marc for sharing your wisdom, expertise, and thoughtful and nuanced perspectives on private markets and real estate. 

The Department of Health and Human Services resumes layoffs following a recent Supreme Court ruling. Physicians could see a Medicare pay increase in a CMS proposed rule. And, shareholders approve Walgreens go-private deal with a private equity company. Those stories and more coming up on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

In this episode of Best in Fest, host Leslie LaPage sits down with powerhouse filmmaking duo Blue and Jason Gerber. From directing award-winning commercials for brands like Walgreens, Chipotle, and Lincoln Park Community Services, to creating emotionally resonant documentaries, this married team shares their evolution from the fast-paced world of high-budget commercials to the deeply personal realm of documentary filmmaking.They unpack their process for winning commercial pitches, the art of co-directing, and the creative inspiration behind their new documentary Dawn Dusk—a powerful story of grief, healing, and wearable art. Learn how they balance artistic integrity with client expectations, how fashion becomes narrative, and what it really takes to tell meaningful stories that last.

During a moment of crisis, Best Buy moved fast by turning a pilot program into a nationwide solution almost overnight.Join hosts Chuck Moxley and Nick Paladino as they talk with Robert Neer and Brent Van Wieringen, former Best Buy product leaders who orchestrated one of retail's most impressive digital transformations. With experience leading consumer-facing digital experiences and customer journey optimization, Robert and Brent share how they scaled curbside pickup from 25% of stores to chain-wide in just 72 hours, plus insights from studying competitors' failed attempts during the same period.Key Actionable Takeaways:Create urgency through customer outcomes, not arbitrary deadlines - Focus teams on solving customer problems rather than hitting dates to avoid artificial chaos and shortcutsExpose your entire team to customer pain points - Put engineers, designers, and product managers directly in front of struggling customers to build genuine mission-driven motivationMeasure success beyond conversion rates - Track lifetime value and downstream impact of customer engagement activities, not just immediate transactionsWant more tips and strategies about creating frictionless customer experiences? Subscribe to our newsletter! https://www.thefrictionlessexperience.com/frictionless/ Download the Black Friday/Cyber Monday eBook: http://bluetriangle.com/ebook-Goods Company Website: goodscompany.io  Robert's LinkedIn: https://www.linkedin.com/in/robertneer/ Brent's LinkedIn: https://www.linkedin.com/in/brentvanw/ Chuck's LinkedIn: https://www.linkedin.com/in/chuckmoxley/ Nick's LinkedIn: https://www.linkedin.com/in/npaladino/Chapters: (00:00) Introduction(01:45) Pre-pandemic curbside pickup foundation(04:00) 72-hour chain-wide rollout during COVID(08:00) Physical and digital coordination challenges(11:00) Breaking down organizational silos(12:45) Enduring lessons from pandemic transformation(18:35) Creating urgency without chaos(24:55) Building mission-driven teams today(27:55) Product management philosophy and myths(30:50) AI's role in product development(35:50) Common misconceptions about frictionless experiences(37:50) Conclusion

Leslie Galer is the Owner of Collaborative Quality Improvement LLC, A Quality and Food Safety Consulting company. She also subcontracts for Commercial Quality Assurance and Food Safety Solutions. Leslie is a highly efficient and results-driven professional with Black Belt and Certified Quality Engineer (CQE) certifications. Over 20 years experience in the Food and Dietary Supplements Industries, focusing on: R&D, factory food safety and quality systems, and quality management. Before founding Collaborative Quality Improvement LLC, Leslie worked in Leadership and Management roles at Kraft Heinz and Walgreens. The Industry 4.0 Podcast with Grantek delivers a look into the world of manufacturing, with a focus on stories and trends that lead to better solutions.   Our guests will share tips and outcomes that will help improve your productivity. You will hear from leading providers of Industrial Control System hardware and software, Grantek experts and leaders at best-in-class industry associations that serve Life Sciences and Food & Beverage manufactures.

In this eye-opening episode of The Brian Nichols Show, we rip the mask off the growing crusade against pharmacy benefit managers (PBMs). Critics claim PBMs are behind rising drug costs, but is that the full story - or just the version Big Pharma wants you to believe? If you've ever looked at your pharmacy receipt and wondered why your medication costs more than your electric bill, you won't want to miss this deep dive. Studio Sponsor: Cardio Miracle - "Unlock the secret to a healthier heart, increased energy levels, and transform your cardiovascular fitness like never before.": CardioMiracle.com/TBNS Brian welcomes economist and researcher Satya Marar from the Mercatus Center to break down how PBMs actually work, why they're being blamed for high drug prices, and what the real drivers of healthcare inflation are. Together, they dismantle the most common talking points against PBMs, including rebate manipulation, lack of transparency, spread pricing, and claims of collusion with insurers. It's a masterclass in separating economic fact from political fiction. We also unpack the emotional tug-of-war between small-town pharmacies and corporate chains. What happens when “Fred's Pharmacy” can't compete with CVS and Walgreens? Is it worth paying more for drugs to keep the local guy afloat - or are there smarter ways to balance access, cost, and community values without wrecking the system? But here's the kicker: what if the real culprit isn't the PBMs at all, but a broken government pricing system and global freeloading by other countries? Yeah, we go there. From Medicare's price models to how the U.S. subsidizes R&D for the world, we expose what's actually driving your pill prices through the roof. If you're sick of the soundbites and want real answers about the mess that is American drug pricing - this episode delivers. Tune in, take notes, and walk away with a smarter, sharper view of healthcare economics than most politicians will ever have. ❤️ Order Cardio Miracle (CardioMiracle.com/TBNS) for 15% off and take a step towards better heart health and overall well-being!

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Mela Lovett. A serial entrepreneur with multiple businesses including: Landscaping (Family Lawn Services) Mortgage lending (commercial and residential) Business consulting (especially on proper business structuring)

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Mela Lovett. A serial entrepreneur with multiple businesses including: Landscaping (Family Lawn Services) Mortgage lending (commercial and residential) Business consulting (especially on proper business structuring)

Is the war on PBMs really about helping patients - or just another power grab dressed up as reform? In this eye-opening episode of The Brian Nichols Show, we rip the mask off the growing crusade against pharmacy benefit managers (PBMs). Critics claim PBMs are behind rising drug costs, but is that the full story - or just the version Big Pharma wants you to believe? If you've ever looked at your pharmacy receipt and wondered why your medication costs more than your electric bill, you won't want to miss this deep dive. We have a new show on Lions of Liberty! The Politicks Podcast! Be sure to subscribe to the standalone Politicks Podcast feed. This is the absolute best way to support the show! Listen and subscribe on Apple Podcasts and Spotify. And remember, they're all Blood Suckers! Studio Sponsor: ⁠Cardio Miracle⁠ - "Unlock the secret to a healthier heart, increased energy levels, and transform your cardiovascular fitness like never before.": ⁠CardioMiracle.com/TBNS⁠ Brian welcomes economist and researcher Satya Marar from the Mercatus Center to break down how PBMs actually work, why they're being blamed for high drug prices, and what the real drivers of healthcare inflation are. Together, they dismantle the most common talking points against PBMs, including rebate manipulation, lack of transparency, spread pricing, and claims of collusion with insurers. It's a masterclass in separating economic fact from political fiction. We also unpack the emotional tug-of-war between small-town pharmacies and corporate chains. What happens when “Fred's Pharmacy” can't compete with CVS and Walgreens? Is it worth paying more for drugs to keep the local guy afloat - or are there smarter ways to balance access, cost, and community values without wrecking the system? But here's the kicker: what if the real culprit isn't the PBMs at all, but a broken government pricing system and global freeloading by other countries? Yeah, we go there. From Medicare's price models to how the U.S. subsidizes R&D for the world, we expose what's actually driving your pill prices through the roof. If you're sick of the soundbites and want real answers about the mess that is American drug pricing - this episode delivers. Tune in, take notes, and walk away with a smarter, sharper view of healthcare economics than most politicians will ever have. Order ⁠Cardio Miracle⁠ (⁠CardioMiracle.com/TBNS⁠) for 15% off and take a step towards better heart health and overall well-being!Submit Listener Questions to ⁠brian@briannicholsshow.com⁠ to hear your questions and perspectives answered and shared each and every week! WATCH The Brian Nichols Show, available on ⁠YouTube⁠ & ⁠Rumble⁠. With over 990 episodes featuring local candidates, elected officials, economists, CEOs, and more, each show educates, enlightens, and informs. Follow Brian on social media: X.com/Twitter ⁠(https://www.briannicholsshow.com/twitter⁠) & Facebook (⁠https://www.briannicholsshow.com/facebook⁠) Don't forget to like, share, and subscribe to ⁠The Brian Nichols Show ⁠for more captivating interviews and insights into common sense solutions for local problems! Learn more about your ad choices. Visit megaphone.fm/adchoices

Between pharmacy closures, drug shortages, technological innovations, and workforce shortages, pharmacies are at a pivot point and must evolve to keep up with this changing environment. In this episode of the Strategic Transformation series, Mindy McGrath, Saurabh Raman, and Ryan Hummel explore how the Pharmacy Channel is reimagining the pharmacist's role from prescription dispensers to trusted, longitudinal care partners.  To learn more about how we can help your team navigate these strategic decisions, reach out to Saurabh.Raman@vynamic.com and Ryan.Hummel@vynamic.com.Podcast Tags: healthcare, pharmacy, pharmacy channel, healthcare strategy, health innovation, strategic transformation Source Links: 2024-2025 Pharmacy Trends Include Improved Drug Shortages, More Pharmacy Closures  Walgreens agrees to be acquired by private equity firm for almost $10 billion Combating the Post-Pandemic Pharmacy Workforce Shortage Honesty/Ethics in Professions CVS reaps benefits of improved pharmacy experience  Why consumer experience is clinically important in health care Walgreens' Move to Go Private: 4 Key Takeaways CVS is expanding its MinuteClinics into primary care. Here's why Where Are Amazon, CVS and Walgreens Headed in Health Care? Panel – Mindy McGrath, Saurabh Raman, Ryan Hummel  Research & Production – Saurabh Raman, Ryan Hummel, Everly Petruzzelli Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

Dr. Paul Hanona and Dr. Arturo Loaiza-Bonilla discuss how to safely and smartly integrate AI into the clinical workflow and tap its potential to improve patient-centered care, drug development, and access to clinical trials. TRANSCRIPT Dr. Paul Hanona: Hello, I'm Dr. Paul Hanona, your guest host of the ASCO Daily News Podcast today. I am a medical oncologist as well as a content creator @DoctorDiscover, and I'm delighted to be joined today by Dr. Arturo Loaiza-Bonilla, the chief of hematology and oncology at St. Luke's University Health Network. Dr. Bonilla is also the co-founder and chief medical officer at Massive Bio, an AI-driven platform that matches patients with clinical trials and novel therapies. Dr. Loaiza-Bonilla will share his unique perspective on the potential of artificial intelligence to advance precision oncology, especially through clinical trials and research, and other key advancements in AI that are transforming the oncology field. Our full disclosures are available in the transcript of the episode. Dr. Bonilla, it's great to be speaking with you today. Thanks for being here. Dr. Arturo Loaiza-Bonilla: Oh, thank you so much, Dr. Hanona. Paul, it's always great to have a conversation. Looking forward to a great one today. Dr. Paul Hanona: Absolutely. Let's just jump right into it. Let's talk about the way that we see AI being embedded in our clinical workflow as oncologists. What are some practical ways to use AI? Dr. Arturo Loaiza-Bonilla: To me, responsible AI integration in oncology is one of those that's focused on one principle to me, which is clinical purpose is first, instead of the algorithm or whatever technology we're going to be using. If we look at the best models in the world, they're really irrelevant unless we really solve a real day-to-day challenge, either when we're talking to patients in the clinic or in the infusion chair or making decision support. Currently, what I'm doing the most is focusing on solutions that are saving us time to be more productive and spend more time with our patients. So, for example, we're using ambient AI for appropriate documentation in real time with our patients. We're leveraging certain tools to assess for potential admission or readmission of patients who have certain conditions as well. And it's all about combining the listening of physicians like ourselves who are end users, those who create those algorithms, data scientists, and patient advocates, and even regulators, before they even write any single line of code. I felt that on my own, you know, entrepreneurial aspects, but I think it's an ethos that we should all follow. And I think that AI shouldn't be just bolted on later. We always have to look at workflows and try to look, for example, at clinical trial matching, which is something I'm very passionate about. We need to make sure that first, it's easier to access for patients, that oncologists like myself can go into the interface and be able to pull the data in real time when you really need it, and you don't get all this fatigue alerts. To me, that's the responsible way of doing so. Those are like the opportunities, right? So, the challenge is how we can make this happen in a meaningful way – we're just not reacting to like a black box suggestion or something that we have no idea why it came up to be. So, in terms of success – and I can tell you probably two stories of things that we know we're seeing successful – we all work closely with radiation oncologists, right? So, there are now these tools, for example, of automated contouring in radiation oncology, and some of these solutions were brought up in different meetings, including the last ASCO meeting. But overall, we know that transformer-based segmentation tools; transformer is just the specific architecture of the machine learning algorithm that has been able to dramatically reduce the time for colleagues to spend allotting targets for radiation oncology. So, comparing the target versus the normal tissue, which sometimes it takes many hours, now we can optimize things over 60%, sometimes even in minutes. So, this is not just responsible, but it's also an efficiency win, it's a precision win, and we're using it to adapt even mid-course in response to tumor shrinkage. Another success that I think is relevant is, for example, on the clinical trial matching side. We've been working on that and, you know, I don't want to preach to the choir here, but having the ability for us to structure data in real time using these tools, being able to extract information on biomarkers, and then show that multi-agentic AI is superior to what we call zero-shot or just throwing it into ChatGPT or any other algorithm, but using the same tools but just fine-tuned to the point that we can be very efficient and actually reliable to the level of almost like a research coordinator, is not just theory. Now, it can change lives because we can get patients enrolled in clinical trials and be activated in different places wherever the patient may be. I know it's like a long answer on that, but, you know, as we talk about responsible AI, that's important. And in terms of what keeps me up at night on this: data drift and biases, right? So, imaging protocols, all these things change, the lab switch between different vendors, or a patient has issues with new emerging data points. And health systems serve vastly different populations. So, if our models are trained in one context and deployed in another, then the output can be really inaccurate. So, the idea is to become a collaborative approach where we can use federated learning and patient-centricity so we can be much more efficient in developing those models that account for all the populations, and any retraining that is used based on data can be diverse enough that it represents all of us and we can be treated in a very good, appropriate way. So, if a clinician doesn't understand why a recommendation is made, as you probably know, you probably don't trust it, and we shouldn't expect them to. So, I think this is the next wave of the future. We need to make sure that we account for all those things. Dr. Paul Hanona: Absolutely. And even the part about the clinical trials, I want to dive a little bit more into in a few questions. I just kind of wanted to make a quick comment. Like you said, some of the prevalent things that I see are the ambient scribes. It seems like that's really taken off in the last year, and it seems like it's improving at a pretty dramatic speed as well. I wonder how quickly that'll get adopted by the majority of physicians or practitioners in general throughout the country. And you also mentioned things with AI tools regarding helping regulators move things quicker, even the radiation oncologist, helping them in their workflow with contouring and what else they might have to do. And again, the clinical trials thing will be quite interesting to get into. The first question I had subsequent to that is just more so when you have large datasets. And this pertains to two things: the paper that you published recently regarding different ways to use AI in the space of oncology referred to drug development, the way that we look at how we design drugs, specifically anticancer drugs, is pretty cumbersome. The steps that you have to take to design something, to make sure that one chemical will fit into the right chemical or the structure of the molecule, that takes a lot of time to tinker with. What are your thoughts on AI tools to help accelerate drug development? Dr. Arturo Loaiza-Bonilla: Yes, that's the Holy Grail and something that I feel we should dedicate as much time and effort as possible because it relies on multimodality. It cannot be solved by just looking at patient histories. It cannot be solved by just looking at the tissue alone. It's combining all these different datasets and being able to understand the microenvironment, the patient condition and prior treatments, and how dynamic changes that we do through interventions and also exposome – the things that happen outside of the patient's own control – can be leveraged to determine like what's the best next step in terms of drugs. So, the ones that we heard the news the most is, for example, the Nobel Prize-winning [for Chemistry awarded to Demis Hassabis and John Jumper for] AlphaFold, an AI system that predicts protein structures right? So, we solved this very interesting concept of protein folding where, in the past, it would take the history of the known universe, basically – what's called the Levinthal's paradox – to be able to just predict on amino acid structure alone or the sequence alone, the way that three-dimensionally the proteins will fold. So, with that problem being solved and the Nobel Prize being won, the next step is, “Okay, now we know how this protein is there and just by sequence, how can we really understand any new drug that can be used as a candidate and leverage all the data that has been done for many years of testing against a specific protein or a specific gene or knockouts and what not?” So, this is the future of oncology and where we're probably seeing a lot of investments on that. The key challenge here is mostly working on the side of not just looking at pathology, but leveraging this digital pathology with whole slide imaging and identifying the microenvironment of that specific tissue. There's a number of efforts currently being done. One isn't just H&E, like hematoxylin and eosin, slides alone, but with whole imaging, now we can use expression profiles, spatial transcriptomics, and gene whole exome sequencing in the same space and use this transformer technology in a multimodality approach that we know already the slide or the pathology, but can we use that to understand, like, if I knock out this gene, how is the microenvironment going to change to see if an immunotherapy may work better, right? If we can make a microenvironment more reactive towards a cytotoxic T cell profile, for example. So, that is the way where we're really seeing the field moving forward, using multimodality for drug discovery. So, the FDA now seems to be very eager to support those initiatives, so that's of course welcome. And now the key thing is the investment to do this in a meaningful way so we can see those candidates that we're seeing from different companies now being leveraged for rare disease, for things that are going to be almost impossible to collect enough data, and make it efficient by using these algorithms that sometimes, just with multiple masking – basically, what they do is they mask all the features and force the algorithm to find solutions based on the specific inputs or prompts we're doing. So, I'm very excited about that, and I think we're going to be seeing that in the future. Dr. Paul Hanona: So, essentially, in a nutshell, we're saying we have the cancer, which is maybe a dandelion in a field of grass, and we want to see the grass that's surrounding the dandelion, which is the pathology slides. The problem is, to the human eye, it's almost impossible to look at every single piece of grass that's surrounding the dandelion. And so, with tools like AI, we can greatly accelerate our study of the microenvironment or the grass that's surrounding the dandelion and better tailor therapy, come up with therapy. Otherwise, like you said, to truly generate a drug, this would take years and years. We just don't have the throughput to get to answers like that unless we have something like AI to help us. Dr. Arturo Loaiza-Bonilla: Correct. Dr. Paul Hanona: And then, clinical trials. Now, this is an interesting conversation because if you ever look up our national guidelines as oncologists, there's always a mention of, if treatment fails, consider clinical trials. Or in the really aggressive cancers, sometimes you might just start out with clinical trials. You don't even give the standard first-line therapy because of how ineffective it is. There are a few issues with clinical trials that people might not be aware of, but the fact that the majority of patients who should be on clinical trials are never given the chance to be on clinical trials, whether that's because of proximity, right, they might live somewhere that's far from the institution, or for whatever reason, they don't qualify for the clinical trial, they don't meet the strict inclusion criteria.  But a reason you mentioned early on is that it's simply impossible for someone to be aware of every single clinical trial that's out there. And then even if you are aware of those clinical trials, to actually find the sites and put in the time could take hours. And so, how is AI going to revolutionize that? Because in my mind, it's not that we're inventing a new tool. Clinical trials have always been available. We just can't access them. So, if we have a tool that helps with access, wouldn't that be huge? Dr. Arturo Loaiza-Bonilla: Correct. And that has been one of my passions. And for those who know me and follow me and we've spoke about it in different settings, that's something that I think we can solve. This other paradox, which is the clinical trial enrollment paradox, right? We have tens of thousands of clinical trials available with millions of patients eager to learn about trials, but we don't enroll enough and many trials close to accrual because of lack of enrollment. It is completely paradoxical and it's because of that misalignment because patients don't know where to go for trials and sites don't know what patients they can help because they haven't reached their doors yet. So, the solution has to be patient-centric, right? We have to put the patient at the center of the equation. And that was precisely what we had been discussing during the ASCO meeting. There was an ASCO Education Session where we talked about digital prescreening hubs, where we, in a patient-centric manner, the same way we look for Uber, Instacart, any solution that you may think of that you want something that can be leveraged in real time, we can use these real-world data streams from the patient directly, from hospitals, from pathology labs, from genomics companies, to continuously screen patients who can match to the inclusion/exclusion criteria of unique trials. So, when the patient walks into the clinic, the system already knows if there's a trial and alerts the site proactively. The patient can actually also do decentralization. So, there's a number of decentralized clinical trial solutions that are using what I call the “click and mortar” approach, which is basically the patient is checking digitally and then goes to the site to activate. We can also have the click and mortar in the bidirectional way where the patient is engaged in person and then you give the solution like the ones that are being offered on things that we're doing at Massive Bio and beyond, which is having the patient to access all that information and then they make decisions and enroll when the time is right.  As I mentioned earlier, there is this concept drift where clinical trials open and close, the patient line of therapy changes, new approvals come in and out, and sites may not be available at a given time but may be later. So, having that real-time alerts using tools that are able already to extract data from summarization that we already have in different settings and doing this natural language ingestion, we can not only solve this issue with manual chart review, which is extremely cumbersome and takes forever and takes to a lot of one-time assessments with very high screen failures, to a real-time dynamic approach where the patient, as they get closer to that eligibility criteria, they get engaged. And those tools can be built to activate trials, audit trials, and make them better and accessible to patients. And something that we know is, for example, 91%-plus of Americans live close to either a pharmacy or an imaging center. So, imagine that we can potentially activate certain of those trials in those locations. So, there's a number of pharmacies, special pharmacies, Walgreens, and sometimes CVS trying to do some of those efforts. So, I think the sky's the limit in terms of us working together. And we've been talking with corporate groups, they're all interested in those efforts as well, to getting patients digitally enabled and then activate the same way we activate the NCTN network of the corporate groups, that are almost just-in-time. You can activate a trial the patient is eligible for and we get all these breakthroughs from the NIH and NCI, just activate it in my site within a week or so, as long as we have the understanding of the protocol. So, using clinical trial matching in a digitally enabled way and then activate in that same fashion, but not only for NCTN studies, but all the studies that we have available will be the key of the future through those prescreening hubs. So, I think now we're at this very important time where collaboration is the important part and having this silo-breaking approach with interoperability where we can leverage data from any data source and from any electronic medical records and whatnot is going to be essential for us to move forward because now we have the tools to do so with our phones, with our interests, and with the multiple clinical trials that are coming into the pipelines. Dr. Paul Hanona: I just want to point out that the way you described the process involves several variables that practitioners often don't think about. We don't realize the 15 steps that are happening in the background. But just as a clarifier, how much time is it taking now to get one patient enrolled on a clinical trial? Is it on the order of maybe 5 to 10 hours for one patient by the time the manual chart review happens, by the time the matching happens, the calls go out, the sign-up, all this? And how much time do you think a tool that could match those trials quicker and get you enrolled quicker could save? Would it be maybe an hour instead of 15 hours? What's your thought process on that? Dr. Arturo Loaiza-Bonilla: Yeah, exactly. So one is the matching, the other one is the enrollment, which, as you mentioned, is very important. So, it can take, from, as you said, probably between 4 days to sometimes 30 days. Sometimes that's how long it takes for all the things to be parsed out in terms of logistics and things that could be done now agentically. So, we can use agents to solve those different steps that may take multiple individuals. We can just do it as a supply chain approach where all those different steps can be done by a single agent in a simultaneous fashion and then we can get things much faster. With an AI-based solution using these frontier models and multi-agentic AI – and we presented some of this data in ASCO as well – you can do 5,000 patients in an hour, right? So, just enrolling is going to be between an hour and maximum enrollment, it could be 7 days for those 5,000 patients if it was done at scale in a multi-level approach where we have all the trials available. Dr. Paul Hanona: No, definitely a very exciting aspect of our future as oncologists. It's one thing to have really neat, novel mechanisms of treatment, but what good is it if we can't actually get it to people who need it? I'm very much looking for the future of that.  One of the last questions I want to ask you is another prevalent way that people use AI is just simply looking up questions, right? So, traditionally, the workflow for oncologists is maybe going on national guidelines and looking up the stage of the cancer and seeing what treatments are available and then referencing the papers and looking at who was included, who wasn't included, the side effects to be aware of, and sort of coming up with a decision as to how to treat a cancer patient. But now, just in the last few years, we've had several tools become available that make getting questions easier, make getting answers easier, whether that's something like OpenAI's tools or Perplexity or Doximity or OpenEvidence or even ASCO has a Guidelines Assistant as well that is drawing from their own guidelines as to how to treat different cancers. Do you see these replacing traditional sources? Do you see them saving us a lot more time so that we can be more productive in clinic? What do you think is the role that they're going to play with patient care? Dr. Arturo Loaiza-Bonilla: Such a relevant question, particularly at this time, because these AI-enabled query tools, they're coming left and right and becoming increasingly common in our daily workflows and things that we're doing. So, traditionally, when we go and we look for national guidelines, we try to understand the context ourselves and then we make treatment decisions accordingly. But that is a lot of a process that now AI is helping us to solve. So, at face value, it seems like an efficiency win, but in many cases, I personally evaluate platforms as the chief of hem/onc at St. Luke's and also having led the digital engagement things through Massive Bio and trying to put things together, I can tell you this: not all tools are created equal. In cancer care, each data point can mean the difference between cure and progression, so we cannot really take a lot of shortcuts in this case or have unverified output. So, the tools are helpful, but it has to be grounded in truth, in trusted data sources, and they need to be continuously updated with, like, ASCO and NCCN and others. So, the reason why the ASCO Guidelines Assistant, for instance, works is because it builds on all these recommendations, is assessed by end users like ourselves. So, that kind of verification is critical, right? We're entering a phase where even the source material may be AI-generated. So, the role of human expert validation is really actually more important, not less important. You know, generalist LLMs, even when fine-tuned, they may not be enough. You can pull a few API calls from PubMed, etc., but what we need now is specialized, context-aware, agentic tools that can interpret multimodal and real-time clinical inputs. So, something that we are continuing to check on and very relevant to have entities and bodies like ASCO looking into this so they can help us to be really efficient and really help our patients. Dr. Paul Hanona: Dr. Bonilla, what do you want to leave the listener with in terms of the future direction of AI, things that we should be cautious about, and things that we should be optimistic about? Dr. Arturo Loaiza-Bonilla: Looking 5 years ahead, I think there's enormous promise. As you know, I'm an AI enthusiast, but always, there's a few priorities that I think – 3 of them, I think – we need to tackle head-on. First is algorithmic equity. So, most AI tools today are trained on data from academic medical centers but not necessarily from community practices or underrepresented populations, particularly when you're looking at radiology, pathology, and what not. So, those blind spots, they need to be filled, and we can eliminate a lot of disparities in cancer care. So, those frameworks to incentivize while keeping the data sharing using federated models and things that we can optimize is key. The second one is the governance on the lifecycle. So, you know, AI is not really static. So, unlike a drug that is approved and it just, you know, works always, AI changes. So, we need to make sure that we have tools that are able to retrain and recall when things degrade or models drift. So, we need to use up-to-date AI for clinical practice, so we are going to be in constant revalidation and make it really easy to do. And lastly, the human-AI interface. You know, clinicians don't need more noise or we don't need more black boxes. We need decision support that is clear, that we can interpret, and that is actionable. “Why are you using this? Why did we choose this drug? Why this dose? Why now?” So, all these things are going to help us and that allows us to trace evidence with a single click. So, I always call it back to the Moravec's paradox where we say, you know, evolution gave us so much energy to discern in the sensory-neural and dexterity. That's what we're going to be taking care of patients. We can use AI to really be a force to help us to be better clinicians and not to really replace us. So, if we get this right and we decide for transparency with trust, inclusion, etc., it will never replace any of our work, which is so important, as much as we want, we can actually take care of patients and be personalized, timely, and equitable. So, all those things are what get me excited every single day about these conversations on AI. Dr. Paul Hanona: All great thoughts, Dr. Bonilla. I'm very excited to see how this field evolves. I'm excited to see how oncologists really come to this field. I think with technology, there's always a bit of a lag in adopting it, but I think if we jump on board and grow with it, we can do amazing things for the field of oncology in general. Thank you for the advancements that you've made in your own career in the field of AI and oncology and just ultimately with the hopeful outcomes of improving patient care, especially cancer patients. Dr. Arturo Loaiza-Bonilla: Thank you so much, Dr. Hanona. Dr. Paul Hanona: Thanks to our listeners for your time today. If you value the insights that you hear on ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:    Dr. Arturo Loaiza-Bonilla @DrBonillaOnc Dr. Paul Hanona @DoctorDiscover on YouTube Follow ASCO on social media:      @ASCO on Twitter      ASCO on Facebook      ASCO on LinkedIn    ASCO on BlueSky Disclosures: Paul Hanona: No relationships to disclose. Dr. Arturo-Loaiza-Bonilla: Leadership: Massive Bio Stock & Other Ownership Interests: Massive Bio Consulting or Advisory Role: Massive Bio, Bayer, PSI, BrightInsight, CardinalHealth, Pfizer, AstraZeneca, Medscape Speakers' Bureau: Guardant Health, Ipsen, AstraZeneca/Daiichi Sankyo, Natera

Is the war on PBMs really about helping patients - or just another power grab dressed up as reform? In this eye-opening episode of The Brian Nichols Show, we rip the mask off the growing crusade against pharmacy benefit managers (PBMs). Critics claim PBMs are behind rising drug costs, but is that the full story - or just the version Big Pharma wants you to believe? If you've ever looked at your pharmacy receipt and wondered why your medication costs more than your electric bill, you won't want to miss this deep dive. We have a new show on Lions of Liberty! The Politicks Podcast! Be sure to subscribe to the standalone Politicks Podcast feed. This is the absolute best way to support the show! Listen and subscribe on Apple Podcasts and Spotify. And remember, they're all Blood Suckers! Studio Sponsor: ⁠Cardio Miracle⁠ - "Unlock the secret to a healthier heart, increased energy levels, and transform your cardiovascular fitness like never before.": ⁠CardioMiracle.com/TBNS⁠ Brian welcomes economist and researcher Satya Marar from the Mercatus Center to break down how PBMs actually work, why they're being blamed for high drug prices, and what the real drivers of healthcare inflation are. Together, they dismantle the most common talking points against PBMs, including rebate manipulation, lack of transparency, spread pricing, and claims of collusion with insurers. It's a masterclass in separating economic fact from political fiction. We also unpack the emotional tug-of-war between small-town pharmacies and corporate chains. What happens when “Fred's Pharmacy” can't compete with CVS and Walgreens? Is it worth paying more for drugs to keep the local guy afloat - or are there smarter ways to balance access, cost, and community values without wrecking the system? But here's the kicker: what if the real culprit isn't the PBMs at all, but a broken government pricing system and global freeloading by other countries? Yeah, we go there. From Medicare's price models to how the U.S. subsidizes R&D for the world, we expose what's actually driving your pill prices through the roof. If you're sick of the soundbites and want real answers about the mess that is American drug pricing - this episode delivers. Tune in, take notes, and walk away with a smarter, sharper view of healthcare economics than most politicians will ever have. Order ⁠Cardio Miracle⁠ (⁠CardioMiracle.com/TBNS⁠) for 15% off and take a step towards better heart health and overall well-being!Submit Listener Questions to ⁠brian@briannicholsshow.com⁠ to hear your questions and perspectives answered and shared each and every week! WATCH The Brian Nichols Show, available on ⁠YouTube⁠ & ⁠Rumble⁠. With over 990 episodes featuring local candidates, elected officials, economists, CEOs, and more, each show educates, enlightens, and informs. Follow Brian on social media: X.com/Twitter ⁠(https://www.briannicholsshow.com/twitter⁠) & Facebook (⁠https://www.briannicholsshow.com/facebook⁠) Don't forget to like, share, and subscribe to ⁠The Brian Nichols Show ⁠for more captivating interviews and insights into common sense solutions for local problems! Learn more about your ad choices. Visit megaphone.fm/adchoices

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Teri Williams. Thanks! The transcript from this episode of Money Making Conversations Masterclass features a powerful and informative interview with Teri Williams, President, COO, and owner of OneUnited Bank, the largest Black-owned bank in the United States. Here's a breakdown of the key highlights and takeaways:

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Teri Williams. Thanks! The transcript from this episode of Money Making Conversations Masterclass features a powerful and informative interview with Teri Williams, President, COO, and owner of OneUnited Bank, the largest Black-owned bank in the United States. Here's a breakdown of the key highlights and takeaways:

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Teri Williams. Thanks! The transcript from this episode of Money Making Conversations Masterclass features a powerful and informative interview with Teri Williams, President, COO, and owner of OneUnited Bank, the largest Black-owned bank in the United States. Here's a breakdown of the key highlights and takeaways:

In this week's Omni Talk Retail Fast Five, sponsored by the A&M Consumer and Retail Group, Simbe, Mirakl, Ocampo Capital, Infios, and ClearDemand, Chris and Anne discussed: - Walmart's “Dinner Tonight” platform launch – The retail giant's one-stop meal solution that lets customers type “Dinner Tonight” or “easy dinner” to access one-click baskets, recipe hubs, and shoppable lists, complete with deli and bakery delivery options. - Amazon's 15-minute grocery delivery partnership with GoPuff in the UK – - The ultra-fast service has expanded from Birmingham and Salford to major cities including London, Manchester, Liverpool, Leeds, Cardiff, Bristol and Sheffield, offering 24/7 grocery delivery through GoPuff's micro-fulfillment network. - Staples pivoting to services for business relevance – The office supply retailer is driving foot traffic through printing, shipping, passport services, and a new Verizon partnership to sell phones and devices in-store, with about 945 locations serving roughly 90% of the U.S. population. (Source) - Sephora's “Delivered to Beauty” partnership with Lyft – The beauty retailer offered $20 Lyft credits for rides to select stores in NYC, LA, San Francisco, Chicago, and Seattle during July 7-10, with customers receiving in-store guidance and $10 off purchases over $50. - Grocery Dealz app launch as the “Gas Buddy of grocery” – The new Dallas-Fort Worth based app allows shoppers to compare grocery prices across supermarkets and build carts, with plans for statewide Texas expansion and eventual national rollout. Plus: This month's OmniStar award goes to Tracey Brown, EVP and Chief Customer Officer at Walgreens, for becoming a licensed pharmacy tech and working weekend shifts to better understand operations and accelerate change. There's all that, plus spicy McMuffins, furniture eulogies, and the new dating trend called “Banksying.” Music by hooksounds.com

In this week's Mom Stomp episode (S4, EP37 - Product Placement & Big Bear Lake, CA), Annie and Jo dive headfirst into hydration mania—from late-night survivalist binge-watching and water-jug car hacks to Yosemite hikes and school water fountains breaks. They also unpack a flying car malfunction at the Beyoncé concert and Annie has a Millennium-concert update straight from Backstreet Boy Kevin. Plus! The Bezos wedding GUEST LIST, Big Bear Lake, CA, the girl singing Moana on the Delta flight and why this pod is lasting FOREVER. Oh, and PRODUCT PLACEMENT. Are you listening, Pepsi, Jurassic Park, Hallmark Channel, Kohl's, Old Navy, Gap, Fenty Beauty, Ulta Beauty, Benefit Cosmetics, Gorilla Glue, Paper Mate, Amazon, The Sphere, Five Below, Walgreens and Dollar Tree?!*This podcast is not appropriate for kids.Instagram and TikTok - momstomppodcastEmail - thismomstomps@gmail.comVM hotline - 213-640-7494Weekly memo and episode recap (which includes links to all things referenced in the ep) here: https://momstomppodcast.substack.com/

"I can mourn what didn't happen while praising God for what did. I can acknowledge that some people didn't show up in the way I'd hoped and still see God's faithfulness in the friend who did."Leave a comment for Karina: https://incourage.me/?p=253363--The summer issue of DaySpring's Everyday Faith magazine is now available! Pick up a copy today on DaySpring.com or at your local Barnes & Noble, Walmart, CVS, Walgreens, or wherever you buy magazines. We hope that this issue helps you know and share God's love in fresh, true, and inspiring ways!The (in)courage podcast is brought to you by DaySpring. For over 50 years, DaySpring has created quality cards, books, and gifts that help you live your faith. Find out more at DaySpring.com.Connect with (in)courage: Facebook & Instagram for daily encouragement, videos, and more! Website for the (in)courage library, to meet our contributors, and to access the archives. Email us at incourage@dayspring.com. Leave a podcast review on Apple!

The (in)courage podcast is taking a brief hiatus from new episodes today as we do some maintenance and updating behind the scenes! We'll return to new daily episodes next week, starting July 7th. In the meantime, we hope you'll enjoy today's episode from our podcast archives!Today's replay is from July 2024. It's a devotional, written by Jen Schmidt and titled Fun Family 4th of July Traditions."Since building traditions into our family's tapestry is a high priority, I love trying to meld the fun with the inspirational. Let's inspire each other. Do you have any special Fourth of July traditions that your family does each year?"--The summer issue of DaySpring's Everyday Faith magazine is now available! Pick up a copy today on DaySpring.com or at your local Barnes & Noble, Walmart, CVS, Walgreens, or wherever you buy magazines. We hope that this issue helps you know and share God's love in fresh, true, and inspiring ways!The (in)courage podcast is brought to you by DaySpring. For over 50 years, DaySpring has created quality cards, books, and gifts that help you live your faith. Find out more at DaySpring.com.Connect with (in)courage: Facebook & Instagram for daily encouragement, videos, and more! Website for the (in)courage library, to meet our contributors, and to access the archives. Email us at incourage@dayspring.com. Leave a podcast review on Apple!

The (in)courage podcast is taking a brief hiatus from new episodes today as we do some maintenance and updating behind the scenes! We'll return to new daily episodes next week, starting July 7th. In the meantime, we hope you'll enjoy today's episode from our podcast archives!Today's replay is from July 2024. It's a devotional, written by Dorina Lazo Gilmore-Young and titled Learning to Love My Body in a Barbie World."Our allegiance isn't to culture; it's to the King. The culture tells us through a barrage of posts, videos, products, and more that we have to make ourselves beautiful. But the Bible tells us something different."--The summer issue of DaySpring's Everyday Faith magazine is now available! Pick up a copy today on DaySpring.com or at your local Barnes & Noble, Walmart, CVS, Walgreens, or wherever you buy magazines. We hope that this issue helps you know and share God's love in fresh, true, and inspiring ways!The (in)courage podcast is brought to you by DaySpring. For over 50 years, DaySpring has created quality cards, books, and gifts that help you live your faith. Find out more at DaySpring.com.Connect with (in)courage: Facebook & Instagram for daily encouragement, videos, and more! Website for the (in)courage library, to meet our contributors, and to access the archives. Email us at incourage@dayspring.com. Leave a podcast review on Apple!

Rick Gates, chief pharmacy officer at Walgreens, joined Over the Counter to discuss the current state of retail pharmacy and the ongoing events that have impacted it.

A shortened show for Chris and Amy includes a visit from UN correspondent Pamela Falk and a look at healthy sports parenting with Jonathan Carone; plus the Diddy verdict is in and a Walgreens follow-up.

In this episode, Cherie Hoeger (CEO & co-founder of Saalt) breaks down the “reusable revolution” in period care—menstrual cups, discs, and patented leak-proof underwear—and shows how a B-Corp can combine product innovation with a global mission to end period poverty. You'll hear practical how-tos, pelvic-floor tips, and a candid look at building a fast-growing fem-tech brand while raising six kids.Timestamps00:00 – 01:00 | Why disposable pads can't solve period poverty01:00 – 04:00 | Meet Cherie & Saalt's reusable mission04:00 – 08:30 | From “diaper-feel” to patented thin-dry underwear08:30 – 17:30 | Live demo: folding, inserting & removing cups vs. discs17:30 – 21:00 | Pelvic-floor support, prolapse & bladder leaks21:00 – 25:30 | 1 % give-back, 130 k donations in 50 countries25:30 – 33:00 | Founder life: in-office preschool & work-life integration33:00 – 38:00 | Hanky Panky collab, retail rollout (Target, Whole Foods, REI)38:00 – 44:00 | Packaging that makes periods “cart-worthy”44:00 – end | Vision: bring Saalt to every girl & end period povertyKey Points• Reusable > Disposable – Cups & discs hold 3-6× a tampon, last 10 + years, and slash monthly costs and waste. • Patented Period Underwear – Saalt spent 3½ years engineering the thinnest, driest tech on the market—now powering Hanky Panky's Confidence Panty line. • Pelvic-Floor Friendly – Discs sit in the posterior fornix (no suction), making them ideal for prolapse, IUDs, heavy lifters, and “sneeze leaks.” • Life-Changing Donations – 130 k products placed in 50 countries; cups keep girls in school and women at work for 10 years on a single purchase. • Customer “Saalt Coaches” – Real humans (not chat-bots) guide users through fit, folds, leaks, PCOS, endo, and more. • Family-First Startup – Cherie & her husband built an on-site preschool and a strict 90-minute “power morning” to juggle six kids and a scaling brand. • Retail Proof – Instagram-worthy packaging helped Saalt hit Target shelves in year 2; now also in Whole Foods, REI, Walmart Teens, and Walgreens.Deep DivesThe Cup & Disc Advantage12-hour wear, medical-grade silicone, hypoallergenic.Discs allow mess-free period sex and added pelvic support.“It's not bigger than a baby's head—yes, it fits!”Underwear Tech & Hanky PankyUltra-thin absorbent gusset keeps the surface bone-dry.Holds 3–6 pads' worth yet feels like everyday lace lingerie.Launched on International Women's Day; sold out first run.Ending Period Poverty—Reusable or BustDisposable donations create endless cost and waste cycles.Cups + education end absenteeism for a decade on ~$30.Saalt targets eight high-need regions; 95 % adoption rate.Pelvic-Floor & Athletic UseDisc + period underwear combo recommended for marathoners.Cups can even outperform pessaries for some bladder-support users.Work-Life Integration BlueprintReplace “balance” with optimization.Morning ritual: reading, strength training, two mission-critical tasks before email.In-office preschool boosts retention & gender equity.Future VisionGlobal accessibility—“Saalt in every country.”Scale 1 % give-back to eradicate period poverty.Keep innovating where stigma once stalled progress (packaging, education, tech).Notable Quotes“Period poverty will never be solved by disposable products.” – Cherie Hoger“We're not selling pads or cups—we're selling confidence.”“A cup in your purse means no more emergency tampon runs.”Find Saalt: saalt.com | Amazon | Target | Whole Foods | REI | Walmart (Teen line)

Mazel morons! This week, we welcome the one and only Catfish legend Nev Schulman. Things get Jewish real fast—Ben shares his Yeshiva past, Nev talks South Williamsburg Shabbat sirens, and Josh becomes the honorary rabbi of Brentwood. The dads go deep on fatherhood, night nurses, and the secret jealousy no one tells you about. Then: Catfish confessions. Nev opens up about the origins of the show, the wildest stories that never made it to air, and how AI might just ruin online love forever. Plus, we weigh in on Caitlin Clark vs. the WNBA, butt-scrunch legging TikToks, and Josh's most embarrassing airport pickup moment. Shabbat shalom indeed, otherwise what are ya nuts?!Leave us a voicemail here!Follow us on Instagram and TikTok! Sponsors:Learn more at Discover.com/creditcardHead to Dentek.com to find your local retailer and shop all of Dentek's products, sold at Target, Walgreens, Amazon and Walmart.Go to www.vivrelle.com and apply for a membership today using code GOODGUYS for 30% off 1 month of membership - the code will also allow you to skip the vivrelle waitlist.Get results you can run your fingers through! For a limited time, Nutrafol is offering our listeners $10 off your first month's subscription and free shipping when you go to Nutrafol.com and enter the promo code GOODGUYS10 If you're ready to build your own business - whether it's merch, products, or the next best idea - get on Shopify.com/goodguys and make it happen!Please note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

So, in the part 1 write-up, I referenced this speech class I took in the summer in high school. This is probably the closest in my experiences to doing something like a Project Runway or Top Chef-style reality show–where you are expected to pump out creation after creation on long hours with very little time to recoup or really think through the thing you're making. You're basically just getting a crash course, then expected to pop out some genius.  Unsurprisingly, I don't remember many of the presentations I put together for this class. Except for one. It starts out much like any episode of Project Runway or Top Chef–Heidi or Padma come out to the contestants, say a witty, scripted preamble, then go into the “Challenge” for the day: prepare a dramatic reading, complete with at least one physical prop. Must be at least three minutes in length. You have one day for this challenge. (I do not remember the teacher at all but am willing to bet she was not Heidi Klum or Padma Lakshmi levels of hot–few of us are.) So after sitting through the presentations from whatever nonsense was assigned yesterday, we are released and allowed to go work on what is due tomorrow.  I hear many people joke about snagging a skull from the science department to do Hamlet, in that sort of desperate way where they're trying to gauge how this would land, because no other ideas are coming and they're dying inside. The idea of trying to learn and be able to recite Shakespeare with one evening's worth of prep did not sound appealing. So like many successful competition-based reality show contestants, I thought about what I knew and how I could fit this challenge to it. Like most moody teens from the early 2000s, I did not know Shakespeare. I did not have Robert Frost or Henry David Thoreau committed to the dome. What did I have embedded in my brain? Song lyrics. The metaphorical lightbulb of genius clicked. I knew what I had to do. And what I had to do was walk over to the nearest Walgreens and buy a puzzle.  The next day, presentations began, and we saw a fair amount of fumbling through Hamlet and other Romantic poets. Someone recreated the space landing audio with a toy spaceship. It was a lot of uninspired mediocre dishes. It was a ton of napkin-style mini-dresses in the unconventional materials challenge. I started to panic–either I messed this up royal, or I've done this better than anyone ever has, and I won't know until I volunteer to get up there and present.  I finally get the nerve, go up there, quiet with my unopened puzzle, knowing I only had one shot at this. This was pre 8 Mile coming out, so I couldn't even mom's spaghetti to hype myself up. I just had to commit. What was I committing to? Well, ripping apart the box of a puzzle, throwing pieces around the room for a full minute before reciting the lyrics to Dashboard Confessional's song “This Ruined Puzzle”. I also apparently committed to giving myself a few gnarly cardboard cuts on the stupid box, but…it landed. I got a 100 on the assignment and Padma would've definitely named me the winner of the challenge. Heidi gave me immunity for next week's show, so I'm definitely not getting eliminated. Love that for me. Shout out to Claire from the last writeup, whose feedback included the joke “But not all of the pieces were face down :( ” which is still objectively hilarious, good job Claire.  What does this have to do with part 2 of our 2024 Musical Wrap-up conversation? You have to embrace who you are and let it drive you. If you are an emo teenage dirtbag, Shakespeare doesn't got you, Chris Carrabba does. Also, a healthy dash of chaos and Committing to the Bit ™ always helps. And that's the TLAT way. Enjoy the episode.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Teri Williams. Thanks! The transcript from this episode of Money Making Conversations Masterclass features a powerful and informative interview with Teri Williams, President, COO, and owner of OneUnited Bank, the largest Black-owned bank in the United States. Here's a breakdown of the key highlights and takeaways:

Picture a young girl planting grapevines at age ten, later rushing to shower and change so she could conduct wine tastings, occasionally interrupted by phone calls about escaped goats reaching the local Walgreens. This storybook childhood, filled with family meatball subs, gardening, and winemaking, formed the foundation for her multifaceted career.Unexpected connections are a recurring theme throughout her life which led her through restaurant ownership, culinary achievements, and eventually to a devastating period during COVID when she lost her 18-year restaurant business through divorce.The turning point? A chance conversation with a stranger on an airplane that connected her to Provocativo, where she now serves as executive winemaker, partnering with pop star Bebe Rexha to create organic sparkling wines that rival champagne at half the price. Her story serves as a powerful reminder that resilience, openness to unexpected opportunities, and the courage to embrace multiple passions can transform even our hardest moments into stepping stones toward fulfilling work.Ready to taste what Brianna has created? Use code GATHER20 for 20% off at provocativobubbles.com and experience the magic for yourself.This Episode is Sponsored by: Travel with Stephani- Are you looking to plan a vacation for your family this Summer? Get access to unique deals, exclusive access and save HOURS on research by working with a travel agent. It doesn't cost you anything at all but saves you loads of stress. Sounds like a dream right? Reach out to her here and on socials @travelwithstephani to learn more about booking a trip to Sandals, Beaches, Disney & more! Support the show

Reporter Ally Marotti talks with host Amy Guth about restaurant business news including Potbelly's turnaround plan, Chicago chefs betting on casino dining, and the first restaurant with direct access to The 606 trail.Plus: Brandon Johnson faces fresh ethics scrutiny after lobbyist donation, Walgreens beats Wall Street expectations ahead of sale to Sycamore Partners, New York firm buys distressed Wacker Drive tower at massive discount and MCA Chicago announces its next board chair.

En el episodio de hoy de VG Daily, Eugenio Garibay y Andre Dos Santos analizan a fondo los reportes financieros más recientes de tres gigantes del mercado: Paychex, Micron Technology y Walgreens Boots Alliance. El episodio arranca con un repaso al desempeño de Micron y su revolucionaria memoria HBM, explicando de manera sencilla cómo funciona esta tecnología, por qué es clave en la era de la inteligencia artificial y cómo está impulsando el crecimiento de la compañía.  Luego, el foco se traslada a Paychex tras su adquisición de Paycor, destacando las sinergias, la estrategia de integración y la reacción de los analistas. Finalmente, se aborda el caso de Walgreens, una empresa que atraviesa un proceso de privatización y reestructuración, enfrentando desafíos en ventas y márgenes, y cuya historia refleja la transformación del sector retail en Estados Unidos. A lo largo del episodio,  Andre y Eugenio aportan datos curiosos, contexto histórico y opiniones relevantes para entender no solo los números, sino también las historias y tendencias que están moviendo el mercado en estos días.

US President Trump may accelerate the announcement of a successor to Fed Chair Powell, according to WSJ sources.Chinese state planner official said with policy implementation and introduction, "we are confident and capable of minimising the adverse impacts from external shock", according to Reuters.Micron (MU) said there may have been some tariff-related pull-ins by certain customers; customer inventory levels have been healthy overall across end markets.European & US indices trade modestly higher, ES +0.3%; Shell has “no intention” of making an offer for BP.DXY hammered amid reports Trump is to name a Powell successor early; a report which has also weighed on US yields.Crude trims initial gains, metals glean strength from the dovish Fed source report, USD weakness and Chinese commentary.Looking ahead, US Durable Goods, GDP Final (Q1), PCE (Q1), Jobless Claims, National Activity Index, Advance Goods Trade Balance, Wholesale Inventories, Banxico Policy Announcement, ECB's de Guindos, Schnabel, Lagarde; BoE's Bailey; Fed's Daly, Barkin, Hammack, Barr, Kashkari, Supply from the US, Earnings from Walgreens, Nike.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

APAC stocks traded mixed in choppy fashion following a similar session on Wall Street, with overnight newsflow relatively light as Israel and Iran seemingly continued to observe the ceasefire.US President Trump may accelerate the announcement of a successor to Fed Chair Powell, according to WSJ sources.Chinese state planner official said with policy implementation and introduction, "we are confident and capable of minimising the adverse impacts from external shock", according to Reuters.HKMA bought HKD 9.42bln as the Hong Kong dollar hit the weak end of its trading range, marking the first such intervention since 2023 to defend the currency peg.Micron (MU) said there may have been some tariff-related pull-ins by certain customers; customer inventory levels have been healthy overall across end markets.Looking ahead, highlights include German GfK Consumer Sentiment, US Durable Goods, GDP Final (Q1), PCE (Q1), Jobless Claims, National Activity Index, Advance Goods Trade Balance, Wholesale Inventories, Banxico Policy Announcement, ECB's de Guindos, Schnabel, Lagarde; BoE's Bailey, Breeden; Fed's Daly, Barkin, Hammack, Barr, Kashkari, supply from US, Earnings from Walgreens, Nike, H&M.Click for the Newsquawk Week Ahead.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Maria Keena, Michael Calhoun and Fred Bodimer take a look at complaints that Walgreens is having a tough time filling prescriptions for its customers. © Allan Jung/ Telegram & Gazette / USA TODAY NETWORK via Imagn Images

Nearly three-quarters of shoppers can't tell the difference between name-brand and private-label products, Walgreens reports quarterly double-digit gains in its U.S. Pharmacy Division, and Shell is reportedly in talks to buy bp. 

Chris and Amy dive deep into the history of the South Broadway Athletic Club with authors of a new book; issues at Walgreens pharmacies; a concert tonite benefits tornado victims; lemonade stands.

Miramos al mercado estadounidense fijándonos en compañías como McCormick, Walgreens, Micron Technology, Jefferies y Nike. Con Rafael Damborenea, profesor de Finanzas en EUDE Business School.

Überwiegend robuste Ergebnisse, einhergehend mit einem Rückgang bei den Erstanträgen für Arbeitslosenhilfe, fachen die Wall Street erneut an. Micron, MillerKnoll, Steelcase und Walgreens konnten allesamt die Ertrags- und Umsatzziele teils deutlich schlagen. Nach dem Closing werden die Ergebnisse von Nike im Fokus stehen. Wir sehen ansonsten eine Welle weiter steigender Kursziele, vor allem im Tech-Sektor. Die UBS schraubt die Ziele für Meta auf atemberaubende $812. Morgan Stanley hebt wiederum das Ziel für Microsoft auf $530 an, und bleibt bei einer Kaufempfehlung. Morgan Stanley, JP Morgan, die Citigroup und viele andere Analysten auch, heben auf breiter Front auch die Ziele und Aussichten von Micron an. Tesla bekommt erstmals seit einige Wochen sehr positive Kommentare eines Analysten. Benchmark habt die Ziele auf $475 an. Dass Tesla die Robotaxis in Austin zunächst kontrolliert und in einem kleinen Umfang startet, zeige, dass man Regulatoren und Passagiere von der Sicherheit des Modells überzeugen wolle. Ein Podcast - featured by Handelsblatt. +++Erhalte einen exklusiven 15% Rabatt auf Saily eSIM Datentarife! Lade die Saily-App herunter und benutze den Code wallstreet beim Bezahlen: https://saily.com/wallstreet +++ +++EXKLUSIVER NordVPN Deal ➼ https://nordvpn.com/Wallstreet Jetzt risikofrei testen mit einer 30-Tage-Geld-zurück-Garantie!+++ +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html

Überwiegend robuste Ergebnisse, einhergehend mit einem Rückgang bei den Erstanträgen für Arbeitslosenhilfe, fachen die Wall Street erneut an. Micron, MillerKnoll, Steelcase und Walgreens konnten allesamt die Ertrags- und Umsatzziele teils deutlich schlagen. Nach dem Closing werden die Ergebnisse von Nike im Fokus stehen. Wir sehen ansonsten eine Welle weiter steigender Kursziele, vor allem im Tech-Sektor. Die UBS schraubt die Ziele für Meta auf atemberaubende $812. Morgan Stanley hebt wiederum das Ziel für Microsoft auf $530 an, und bleibt bei einer Kaufempfehlung. Morgan Stanley, JP Morgan, die Citigroup und viele andere Analysten auch, heben auf breiter Front auch die Ziele und Aussichten von Micron an. Tesla bekommt erstmals seit einige Wochen sehr positive Kommentare eines Analysten. Benchmark habt die Ziele auf $475 an. Dass Tesla die Robotaxis in Austin zunächst kontrolliert und in einem kleinen Umfang startet, zeige, dass man Regulatoren und Passagiere von der Sicherheit des Modells überzeugen wolle. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

MDJ Script/ Top Stories for June 25th Publish Date:  June 25th    Commercial: From the BG Ad Group Studio, Welcome to the Marietta Daily Journal Podcast.    Today is Wednesday, June 25th and Happy Birthday to Mick Fleetwood. I’m Keith Ippolito and here are the stories Cobb is talking about, presented by Times Journal Marietta Schools Foundation appoints new executive director Cobb, cities to meet over new sales tax referendum Cobb to consider in-house paramedic program All of this and more is coming up on the Marietta Daily Journal Podcast, and if you are looking for community news, we encourage you to listen and subscribe!  BREAK: TIDWELL TREES_FINAL STORY 1: Marietta Schools Foundation appoints new executive director The Marietta Schools Foundation has appointed Laura Kraus, a Marietta City Schools alumna, as its first female executive director, succeeding Joe Kinstle. Established in 1983, the nonprofit supports students, teachers, and district initiatives through scholarships, teacher awards, and funding for classroom needs. Kraus, a former teacher and administrator, aims to expand the foundation’s impact across the district. With over $2 million awarded in scholarships and endowments, the foundation continues to grow, supporting the community with a focus on educational excellence and service to Marietta City Schools. STORY 2: Cobb, cities to meet over new sales tax referendum The Cobb Board of Commissioners will meet with mayors of the county’s seven cities this week to discuss the 2028 SPLOST referendum, a 1% sales tax funding infrastructure projects. Each city will present its project priorities, with a focus on roads, transportation, and community needs. The current SPLOST, collecting $750 million, ends in 2027. A draft project list is due by October, with public feedback sessions in early 2026. Voters will decide on the package in November 2026. Officials aim to address rising costs and ensure impactful projects to gain voter support. STORY 3: Cobb to consider in-house paramedic program The Cobb Board of Commissioners will vote on an agreement with MetroAtlanta Ambulance Service to establish an in-house paramedic program at Cobb Fire & Emergency Services. The program aims to double the number of paramedics trained annually, expanding care and serving as a recruitment tool. Limited to employees of Cobb Fire or MetroAtlanta, the program will cost $650 per student, significantly less than typical tuition. Cobb Fire will provide classroom space and instructors, while MetroAtlanta oversees accreditation and enrollment. Officials see this as a cost-effective way to increase paramedics and improve community emergency services. We have opportunities for sponsors to get great engagement on these shows. Call 770.799.6810 for more info.  We’ll be right back. Break: TOP TECH_FINAL STORY 4: Cobb faces shortfall in '26 general fund budget Cobb County staff will brief commissioners on a $7 million shortfall in the $644.5 million general fund budget for next year. Proposed solutions include raising the millage rate, eliminating commissioners’ $200,000 contingency funds, maintaining a 5% water revenue transfer, cutting $1 million in public safety overtime, and shifting 0.05 mills from the fire fund to the general fund. The budget doesn’t account for 290 new staff requests, costing $27.8 million, while the county still has 468 vacant positions, primarily in police, fire, and water departments. STORY 5: Events: Celebrate July Fourth in Cobb County Cobb County offers several Independence Day celebrations: - **July 3**: Kennesaw’s Salute to America (6-10 p.m.) features live music, kids' activities, and fireworks at 9:30 p.m. Six Flags Over Georgia (July 3-6) offers rides and fireworks nightly. - **July 4**: Marietta’s Fourth in the Park includes a parade (10 a.m.), concerts, and fireworks at dark. Acworth hosts live music (5:30 p.m.) and fireworks at Lake Acworth (9:30 p.m.). Powder Springs features a car show, live bands, and fireworks at 9:30 p.m. Truist Park combines a Braves game (7:15 p.m.) with post-game fireworks. Enjoy food, music, and patriotic fun across the county! Break: INGLES 7 STORY 6: CDPH offering free HIV testing in honor of National HIV Testing Day June 27 is National HIV Testing Day, emphasizing the importance of early diagnosis and linking individuals to care. Cobb & Douglas Public Health (CDPH) will offer free HIV testing at Walgreens in Austell from 2-6 p.m. and continues to provide free testing at its health centers. Testing helps prevent HIV through tools like PrEP and condoms or enables rapid treatment for those who test positive. Cobb County, identified as a high-incidence area, is part of a federal initiative to end HIV by 2030. Free OraQuick self-test kits are also available for pick-up or delivery. STORY 7: 'Out on the water': Professional wakeboarding tour returns to Allatoona The Pro Wakeboard Tour made a splash at Allatoona Lake in Acworth, where professional and amateur wakeboarders, wakesurfers, and jet skiers showcased thrilling tricks and flips. The event, part of a national competition, aims to crown a champion while promoting the sport’s growth and family-friendly appeal. Acworth’s strong support, with hundreds of spectators and boats, makes it a favorite stop for athletes like 10-time jet ski champion Lee Stone and pro wakeboarder Noah Wildman. This marks nearly 20 years of the tour visiting Allatoona Lake, with the next stop set for July in Florida. We’ll have closing comments after this. Break: TOP TECH_FINAL Signoff-   Thanks again for hanging out with us on today’s Marietta Daily Journal Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.mdjonline.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com tidwelltrees.com toptechmech.com #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

Your events shouldn't feel like they're held together by duct tape.But when processes are unclear or inherited from chaos, it's hard to know where to start—especially if you're stepping into a new event marketing role or revamping an existing one.That's where Matt Bohn comes in. Now Field Marketing Manager at Tines, he's spent the past 20 years building scalable, structured event programs for brands like Walgreens and fast-growing tech companies.In this episode, he joins Matt Kleinrock to talk about the real (and often messy) work of creating better systems:✅ The first steps to take when inheriting (or overhauling) an event marketing program✅ How to streamline cross-functional collaboration with legal, sales, and ops✅ The small things that make a big difference—like naming conventions, templates, and intake formsTune in if you've ever thought, “There's gotta be a better way to do this.”----------------------------------Connect with Matt BohnLinkedIn: https://www.linkedin.com/in/matthewjbohn24/ Connect with Matt KleinrockLinkedIn: https://www.linkedin.com/in/matt-kleinrock-9613b22b/  Company: https://rockwayexhibits.com/    

#859: Join us as we sit down with Arthur Brooks – Harvard professor, best-selling author, & leading happiness expert who helps people build more meaningful, purpose-driven lives. From his early career as a classical musician to becoming one of the most sought-after voices on emotional well-being, Arthur shares the science-backed tools & personal insights that can help anyone build a life filled with joy, connection, & fulfillment. He blends science with soul – using research, real-life stories, & timeless wisdom to help people build lives they actually want. Whether he's teaching at Harvard, writing for The Atlantic, or co-authoring books with Oprah, Arthur's work is all about one thing: helping you thrive. In this episode, Arthur dives into the science of happiness, unpacks practical strategies for emotional regulation, breaks down the impact of success addiction, shares tips for deepening marriage & relationship dynamics, emphasizes the importance of boundaries with technology, & explores how real human connection enhances our well-being.   To Watch the Show click HERE   For Detailed Show Notes visit TSCPODCAST.COM   To connect with Arthur Brooks click HERE   To connect with Lauryn Bosstick click HERE   To connect with Michael Bosstick click HERE   Read More on The Skinny Confidential HERE   Head to our ShopMy page HERE and LTK page HERE to find all of the products mentioned in each episode.   Get your burning questions featured on the show! Leave the Him & Her Show a voicemail at +1 (512) 537-7194.   To learn more about Arthur Brooks and read more into his studies visit https://arthurbrooks.com.    Visit c1p.org to donate to the Community First Project, a mission to make communities safer by ensuring the quality & integrity of our nation's law enforcement agencies.   This episode is sponsored by Smart Mouth Never have bad breath again! Find SmartMouth at Walgreens, Walmart, and Amazon or visit http://smartmouth.com/skinny to snag a special discount on your next SmartMouth purchase.   This episode is sponsored by Jenni Kayne Go to http://jennikayne.com and use the code SKINNY15 to get 15% off.    This episode is sponsored by Astral House Marg Summer is here!!! Time to stock up! Go to http://astraltequila.com to find Astral near you - and don't forget the limes! Please Enjoy Responsibly. Do not forward to anyone under 21. ASTRAL Tequila. 40% Alc/Vol. Diageo, New York, NY.   This episode is sponsored by Fora Travel So whether you're looking to plan a trip or build a business planning trips - http://visitforatravel.com/skinny and let them know you came from SKINNY to learn what it means to travel, upgraded.   This episode is sponsored by Just Thrive Visit https://justthrivehealth.com/discount/TSC and use promo code TSC for 20% off your first order.  Produced by Dear Media

Matt Brown, VP of Telehealth at Advisory Services at CHG Healthcare, discusses the current state and future of telehealth, including the rapid adoption during the COVID-19 pandemic, the role of technology and AI in enhancing telehealth experiences, and how telehealth can help address physician and nurse burnout. Improved internet access, mobile device usage, and consumer preferences for convenience have driven the increasing telehealth usage for initial visits, follow-up appointments, and chronic care management.   Matt explains, "We are the nation's largest staffing agency. So, we're actually the founders of what's known as the locum tenens marketplace. CHG has been a pioneer in bringing physician services into remote and rural locations across the United States for the past four years. And over the last 10 years or so, we've continued to innovate on top of that physician-led experience and started to bring technology operations, as well as consulting services and telehealth, into the marketplace. So think of us as providing a broad array of staffing services, but also on top of that, technology and operations, and consulting that help the largest health systems in the country manage their physician workforce."   "It's been widely adopted since the pandemic. If you think about coming out of the pandemic, a lot of our health systems and hospitals were really forced to do a few things. One, they really had to upgrade a lot of their infrastructure and technology. So that meant that they were bringing broadband access into their hospitals. They started to think about how they could deliver care to their patients more remotely. And as they were doing a lot of these technology upgrades, they also started to address patients more like consumers. So I think that there was a big shift that started to take place in consumer services, starting to look like healthcare services."   "About that same time, you had a number of very large retail-focused, consumer-focused companies start to enter into the healthcare marketplace. So these are folks like Amazon, you have CVS and Walgreens, and now you've had a number of companies like Hims and Hers, and all of those are entering into the healthcare ecosystem through telehealth as a channel. So, as we've seen this increased infrastructure, this improvement in infrastructure, as well as consumerization of healthcare, continue to accelerate after the pandemic, and now we have more of this consumer-centric focus coming from a retail perspective."   #CHFGHealthcare #MedAI #DigitalHealth #PatientAccess #Telehealth #PhysicianBurnout #ClinicianBurnout CHGHealthcare.com Download the transcript here

Matt Brown, VP of Telehealth at Advisory Services at CHG Healthcare, discusses the current state and future of telehealth, including the rapid adoption during the COVID-19 pandemic, the role of technology and AI in enhancing telehealth experiences, and how telehealth can help address physician and nurse burnout. Improved internet access, mobile device usage, and consumer preferences for convenience have driven the increasing telehealth usage for initial visits, follow-up appointments, and chronic care management.   Matt explains, "We are the nation's largest staffing agency. So, we're actually the founders of what's known as the locum tenens marketplace. CHG has been a pioneer in bringing physician services into remote and rural locations across the United States for the past four years. And over the last 10 years or so, we've continued to innovate on top of that physician-led experience and started to bring technology operations, as well as consulting services and telehealth, into the marketplace. So think of us as providing a broad array of staffing services, but also on top of that, technology and operations, and consulting that help the largest health systems in the country manage their physician workforce."   "It's been widely adopted since the pandemic. If you think about coming out of the pandemic, a lot of our health systems and hospitals were really forced to do a few things. One, they really had to upgrade a lot of their infrastructure and technology. So that meant that they were bringing broadband access into their hospitals. They started to think about how they could deliver care to their patients more remotely. And as they were doing a lot of these technology upgrades, they also started to address patients more like consumers. So I think that there was a big shift that started to take place in consumer services, starting to look like healthcare services."   "About that same time, you had a number of very large retail-focused, consumer-focused companies start to enter into the healthcare marketplace. So these are folks like Amazon, you have CVS and Walgreens, and now you've had a number of companies like Hims and Hers, and all of those are entering into the healthcare ecosystem through telehealth as a channel. So, as we've seen this increased infrastructure, this improvement in infrastructure, as well as consumerization of healthcare, continue to accelerate after the pandemic, and now we have more of this consumer-centric focus coming from a retail perspective."   #CHFGHealthcare #MedAI #DigitalHealth #PatientAccess #Telehealth #PhysicianBurnout #ClinicianBurnout CHGHealthcare.com Listen to the podcast here

#858: Join us as we sit down with Suebelle Robbins – a beloved style icon & social media personality, also known as Suebelle from Palm Beach. Celebrated for her timeless fashion, elegant beauty tips, & daily outfit inspiration! As a standout in Palm Beach's vibrant social scene, Suebelle gets real about classic fashion that never goes out of style, the beauty of confidence through personal style, her take on relationships, & what life is really like behind the curated charm of Palm Beach culture.   To Watch the Show click HERE   For Detailed Show Notes visit TSCPODCAST.COM   To connect with Suebelle Robbins click HERE   To connect with Lauryn Bosstick click HERE   To connect with Michael Bosstick click HERE   Read More on The Skinny Confidential HERE   Head to our ShopMy page HERE and LTK page HERE to find all of the products mentioned in each episode.   Get your burning questions featured on the show! Leave the Him & Her Show a voicemail at +1 (512) 537-7194.   This episode is sponsored by The Skinny Confidential For a better choice and peace of mind in your home, shop The Skinny Confidential Non-Toxic Toilet Paper at http://shopskinnyconfidential.com.    This episode is sponsored by Smart Mouth Never have bad breath again! Find SmartMouth at Walgreens, Walmart, and Amazon or visit http://smartmouth.com/skinny to snag a special discount on your next SmartMouth purchase.   This episode is sponsored by Astral Tequila House Marg Summer is here. Time to stock up! Go to http://astraltequila.com to find Astral near you - and don't forget the limes! Please Enjoy Responsibly. Do not forward to anyone under 21. ASTRAL Tequila. 40% Alc/Vol. Diageo, New York, NY.   This episode is sponsored by Bobbie  Bobbie is offering an additional 10% off on your purchase with the code TSC. Visit http://hibobbie.com to find the Bobbie formula that fits your journey.   This episode is sponsored by Taylor Farms To learn more visit http://TaylorFarms.com.   This episode is sponsored by DailyLook For 50% off your order, head to http://DailyLook.com and use code SKINNY.   Produced by Dear Media  

A Friday full of VarietyFirst,  a look at this day in History.Then, The Chase and Sanborn Hour, originally broadcast June 20, 1937, 88 years ago with guest Mae Robison. Charlie McCarthy gets a lesson from a "French" tutor.  Mae Robson ("A grand old lady of the theatre") appears in scenes from, "The Old Lady Shows Her Medals." On Father's day, W. C. Fields remembers his father, a doctor who treated a man for yellow jaundice for years before learning he was a Chinaman. Charlie wants to call W. C. Fields "Dad." Bill tells him to "go look in the woodpile."Followed by The Walgreens 44th Birthday Party, originally broadcast June 20, 1945, 80 years ago.   A Seventh War Loan Program. The first tune is, "Those Caissons Go Rolling Along." Paulette Goddard appears in a drama titled, "The Most Beautiful Girl In Missouri." Sidney Fields substitutes for Bud Abbott in a "Who's On First" routine with Lou Costello. Finally. The Couple Next Door starring Peg Lynch and Alan Bunce, originally broadcast June 20, 1960, 65 years ago, Living Room Rug Red Spot. Thanks to Richard G for supporting our podcast by using the Buy Me a Coffee function at http://classicradio.streamFind the Family Fallout Shelter Booklet Here: https://www.survivorlibrary.com/library/the_family_fallout_shelter_1959.pdfhttps://wardomatic.blogspot.com/2006/11/fallout-shelter-handbook-1962.html

Mazel morons! Today we're joined by The Office legend, actor, author, and spiritual explorer Rainn Wilson—and yes, it gets weird in the best way. We talk residual injustice (hi, Drake & Josh), redefining masculinity, 12-step spirituality, and the emotional damage caused by banana bread. Rainn opens up about the spiritual power of theater, the loneliness epidemic, and how Dwight Schrute almost didn't exist. Plus, we unpack the narcissism of both self-hate and overconfidence, why organized religion isn't all bad, and why sound baths slap. What are ya, nuts?Listen to Soul Boom with Rainn WilsonLeave us a voicemail here!Follow us on Instagram and TikTok! Sponsors:David is offering my listeners a deal to buy four cartons and get the fifth free, at davidprotein.com/goodguys Get 25% off @goPure with code GOODGUYS at https://gopurebeauty.com/GOODGUYS #goPurepodGo to brooklynbedding.com and use my promo code goodguys at checkout to get 30% off sitewide. Head to Dentek.com to find your local retailer and shop all of Dentek's products, sold at Target, Walgreens, Amazon and Walmart.Go to www.vivrelle.com and apply for a membership today using code GOODGUYS for 30% off 1 month of membership - the code will also allow you to skip the vivrelle waitlist.Please note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this Ask Me Anything episode, Dr. Will Cole and his team dive deep into your most fascinating health questions - from whether getting your blood drawn can actually make you feel worse, to the viral claim that Lyme disease was engineered as a bio weapon. They also explore the functional medicine take on geographic tongue, and what it could be signaling about your gut, immunity, and nutrient levels. Plus, they address a listener's question about fatty liver: can it be reversed, or is it too late once scarring sets in? If you're curious about labs, latent symptoms, or what's really behind some of the most misunderstood health conditions, this episode is for you. For all links mentioned in this episode, visit www.drwillcole.com/podcastPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors: If you're ready to truly nourish your skin and body from within, Pique is offering 20% off plus a FREE rechargeable frother and glass beaker with my exclusive link: Piquelife.com/WillCole. Go to beekeepersnaturals.com/WILLCOLE or enter code WILLCOLE to get 20% off your order. Beekeeper's Naturals products are also available at Target, Whole Foods, Amazon, CVS, and Walgreens.Get 5 dollars off your next order at MagicSpoon.com/WILLCOLE or look for Magic Spoon on Amazon or in your nearest grocery store.You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/WILLCOLE and using code WILLCOLE at checkout.Go to Quince.com/willcole for 365-day returns, plus free shipping on your order.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In hour tua , We take a look at the Miami Heat's pursuit of Suns Forward Kevin Durant, Game 4 of the Stanley Cup Final is tonight and with the Cats leading the series 2-1 will the Oilers make a goalie change? We make fun of Frog for buying ranch dressing at Walgreen's for a function at Leroy's.

#842: Join us as we sit down with the hosts of SHE MD  – world renowned OBGYN Dr. Thaïs Aliabadi, “Dr. A,” & women's advocate and influencer, Mary Alice Haney. This powerhouse duo brings unfiltered, impactful conversations to the SHE MD podcast with celebrity guests & today's top experts, covering essential women's health topics like menopause, PCOS, endometriosis, & fertility – on a mission to empower women with the knowledge & tools they need to become their own best health advocates. In this episode, Dr. A & Mary Alice take a deep dive into the challenges & implications of PCOS & endometriosis, highlight the importance of early mammogram screenings, & create a roadmap for women struggling with health issues.They also break down the growing conversation around weight loss medications such as ozempic & provide actionable early detection resources for breast cancer & PCOS – continuing their mission to drive awareness, education, & advocacy in women's health!   To Watch the Show click HERE   For Detailed Show Notes visit TSCPODCAST.COM   To connect with SHE MD click HERE   To connect with Dr. Thaïs Aliabadi click HERE   To connect with Mary Alice Haney click HERE   To connect with Lauryn Bosstick click HERE   To connect with Michael Bosstick click HERE   Read More on The Skinny Confidential HERE   Get your burning questions featured on the show! Leave the Him & Her Show a voicemail at +1 (512) 537-7194.   This episode is brought to you by The Skinny Confidential   Head to the HIM & HER Show ShopMy page HERE and LTK page HERE to find all of Michael and Lauryn's favorite products mentioned on their latest episodes.   To learn more about SHE MD and take their risk assessment tests visit shemdpodcast.com.   Join us on May 17th in Los Angeles for The Dear Media Edit, a live wellness experience with your favorite hosts and top voices in health and wellness—tickets available now at DearMedia.com/events.   This episode is sponsored by SmartMouth Find SmartMouth at Walgreens, Walmart, Amazon or visit smartmouth.com/skinny to snag a special discount on your next SmartMouth purchase.   This episode is sponsored by Squarespace Go to Squarespace.com for a free trial, and when you're ready to launch, squarespace.com/SKINNY to save 10% off your first purchase of a website or domain.   This episode is sponsored by Cymbioktika Go to Cymbiotika.com/TSC to get 20% off plus free shipping.    This episode is sponsored by Just Thrive Go to JustThrive.com and use code TSC for 20% off your first order.   This episode is sponsored by Fatty15 Fatty15 is on a mission to replenish your C15 levels and restore your long-term health. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/SKINNY and using code SKINNY at checkout.   This episode is sponsored by Spritz Society Spritz Society is now available everywhere! Head to spritzsociety.com to find a store near you, and make sure to follow @spritz on Instagram for all their latest announcements and upcoming events. Spritz Society, Summer Starts Here!   Produced by Dear Media